FDA loosens restrictions on OTC smoking cessation aids
This article was originally published in Scrip
Executive Summary
After reviewing scientific research on the safety of over-the-counter (OTC) nicotine replacement therapies (NRTs), such as gum, lozenges and transdermal patches, the US FDA has decided that some warnings and limitations specified in the directions for use on the labels of those products are no longer necessary to ensure they are used safely and effectively to quit smoking, regulators said on 1 April.